Abstract
ObjectivesTo assess the incidence and the impact of carbapenem-resistant Acinetobacter baumannii (CRAB) intestinal carriage on subsequent CRAB infection and to study risk factors of acquiring CRAB intestinal carriage among patients in intensive care unit (ICU).DesignObservational study including a case–control study and a retrospective cohort study.SettingA 50-bed general ICU of a university hospital, China.MethodsFrom May 2017 to April 2018, an observational study was conducted in a 50-bed general ICU of a university hospital in China. Rectal swabs were collected from ICU patients on admission and thereafter weekly. A case–control study was performed to analyse risk factors of the acquisition of CRAB intestinal carriage in ICU using multiple logistic regression. A retrospective cohort study was performed to address whether intestinal CRAB carriage could lead to an increased likelihood of subsequent CRAB infection using subdistribution hazard model regarding death in the ICU as a competing risk event.ResultsCRAB intestinal carriage was detected in 6.87% (66/961; 95% CI 5.27% to 8.47%) of patients on ICU admission, whereas 11.97% (115/961; 95% CI 9.91% to 14.02%) of patients acquired CRAB intestinal carriage during the ICU stay. Pancreatitis (OR 2.16, 95% CI 1.28 to 3.67), haematological disease (OR 2.26, 95% CI 1.42 to 3.58), gastric tube feeding (OR 3.35, 95% CI 2.03 to 5.51) and use of carbapenems (OR 1.84, 95% CI 1.11 to 3.07) were independent risk factors for acquiring CRAB intestinal carriage. The incidence of subsequent CRAB infection was 2.24-fold in patients with CRAB intestinal carriage compared with that in patients without (95% CI 1.48 to 3.39, p<0.001).ConclusionMore patients acquired CRAB intestinal carriage during their ICU stay than had on admission. Severity of illness, acute pancreatitis, tube feeding and use of carbapenems were independent risk factors of acquisition of CRAB intestinal carriage. Patients with CRAB intestinal carriage are more likely to develop CRAB infection.
Funder
West China Hospital of Sichuan University
the Newton Advanced Fellowship, Royal Society, UK
National Natural Science Foundation of China
Reference33 articles.
1. Clinical and Pathophysiological Overview of Acinetobacter Infections: a Century of Challenges
2. The prevalence of healthcare-associated infections in mainland China: a systematic review and meta-analysis;Wang;Infect Control Hosp Epidemiol,2018
3. CDC . The biggest antibiotic-resistant threats in the US. centers for disease control and prevention, 2019. Available: https://www.cdc.gov/drugresistance/biggest_threats.html [Accessed 7 Aug 2019].
4. Global priority list of antibiotic-resistant bacteria to guide research, discovery and development of new antibiotics. Available: http://apps.who.int/medicinedocs/en/m/abstract/Js23171en/ [Accessed 7 Aug 2019].
5. European Centre for Disease Prevention and Control . Surveillance of antimicrobial resistance in Europe – annual report of the European antimicrobial resistance surveillance network (EARS-Net) 2017. Stockholm: ECDC, 2018.
Cited by
9 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献